The Promising Link Among Tumor Mutational Burden, Immune-Related Adverse Events, and Immune Checkpoint Inhibitors Efficacy in SCLC

Detalles Bibliográficos
Autor principal: Cortellini, Alessio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474225/
https://www.ncbi.nlm.nih.gov/pubmed/34589959
http://dx.doi.org/10.1016/j.jtocrr.2020.100080

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474225/
https://www.ncbi.nlm.nih.gov/pubmed/34589959
http://dx.doi.org/10.1016/j.jtocrr.2020.100080

Ejemplares similares